Mayo Clinic Proceedings

Mayo Clinic Proceedings Journal

Publication venue for

Progression to Insulin Therapy in Patients With Type 2 Diabetes According to Cardiorespiratory Fitness, Body Mass Index, and Statin Therapy. 99:249-259. 2024
More Potent Antiplatelet Therapy in Acute Coronary Syndrome Patients With Prior Stroke: Proceed With Caution?. 98:1590-1592. 2023
Predicting the Future in Primary Care Patients Through Graded Exercise Testing. 98:1270-1272. 2023
Air Pollution, Physical Activity, and Lifespan. 98:1113-1115. 2023
Association of Glucosamine Supplementation and Incidence of Heart Failure. 98:1118-1120. 2023
Factors Associated With Sex Disparities in Leisure-Time Physical Activity: An Analysis of the Behavioral Risk Factor Surveillance System, 2011 to 2021. 98:997-1008. 2023
Hormones and COVID-19. 98:1098-1099. 2023
Height Explains Sex Difference in Atrial Fibrillation Risk: Copenhagen General Population Study. 98:846-855. 2023
Trends in Metabolic Phenotypes of Obesity Among US Adolescents, NHANES 1999-2018. 98:633-636. 2023
In Reply: ACEI and ARB - Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation. 98:351-352. 2023
Physical Activity and Cardiorespiratory Fitness as Modulators of Health Outcomes: A Compelling Research-Based Case Presented to the Medical Community. 98:316-331. 2023
Trends in Heart Failure Outcomes From a Large, Geographically Diverse Cohort During the COVID-19 Pandemic. 98:4-6. 2023
Brave New World: Improving Obesity and Preventing Cardiovascular Disease. 98:11-14. 2022
Racial Disparities and Excess Cardiovascular Mortality Before and During the COVID-19 Pandemic: Time for a Solution. 97:2180-2183. 2022
Effect of the Renin-Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials. 97:1808-1823. 2022
Effects of Replacing Sedentary Time With Physical Activity on Mortality Among Patients With Heart Failure: National Health and Nutrition Examination Survey Follow-Up Study. 97:1897-1903. 2022
Trends in Metabolic Phenotypes According to Body Mass Index Among US Adults, 1999-2018. 97:1664-1679. 2022
Racial Differences and Social Determinants of Health in Achieving Hypertension Control. 97:1462-1471. 2022
Coronary Artery Calcium and Cardiorespiratory Fitness: The Simple Keys to Truly Personalized Atherosclerotic Cardiovascular Disease Risk Prediction?. 97:1226-1229. 2022
Importance of More Potent Antiplatelet Therapy in Myocardial Infarction With Cardiac Arrest or Cardiogenic Shock. 97:1041-1043. 2022
Making the Case to Measure and Improve Cardiorespiratory Fitness in Routine Clinical Practice. 97:1038-1040. 2022
Understanding Heart Failure Risk in a Diverse Cohort With Human Immunodeficiency Virus Infection (vol 97, pg 433, 2022). 97:1217-1217. 2022
Association Between Personal Activity Intelligence and Mortality: Population-Based China Kadoorie Biobank Study. 97:668-681. 2022
Understanding Heart Failure Risk in a Diverse Cohort With Human Immunodeficiency Virus Infection. 97:433-435. 2022
In Reply-Association Between Weekly Exercise Time and Mortality. 97:421-422. 2022
Updated Reference Standards for Cardiorespiratory Fitness Measured with Cardiopulmonary Exercise Testing: Data from the Fitness Registry and the Importance of Exercise National Database (FRIEND). 97:285-293. 2022
Racial Differences and Social Determinants of Health in Achieving Hypertension Control. 97. 2022
(BMH).. 96:3130-3141. 2021
Development and Validation of a Multivariable Risk Prediction Model for COVID-19 Mortality in the Southern United States. 96:3030-3041. 2021
Synergistic Assessment of Mortality Risk According to Body Mass Index and Exercise Ability and Capacity in Patients Referred for Radionuclide Stress Testing. 96:3001-3011. 2021
U-Shaped Association Between Duration of Sports Activities and Mortality: Copenhagen City Heart Study. 96:3012-3020. 2021
Here's to Your Health: Why a Drink With Dinner Might Improve Longevity. 96:1706-1709. 2021
Omega-3 Benefits Remain Strong Post-STRENGTH. 96:1371-1372. 2021
Safety of Convalescent Plasma Transfusion. 96:1368-1368. 2021
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p. 95:1222-1230. 2020
Association of Obesity With More Critical Illness in COVID-19. 95:2040. 2020
Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States. 95:1865-1876. 2020
Development of Global Reference Standards for Directly Measured Cardiorespiratory Fitness: A Report From the Fitness Registry and Importance of Exercise National Database (FRIEND). 95:255-264. 2020
Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. 95:929-943. 2020
Famotidine Against SARS-CoV2: A Hope or Hype?. 95:1797-1799. 2020
In reply - Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. 95:1553-1556. 2020
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. 95:1445-1453. 2020
Pulmonary Hypertension: A Brief Guide for Clinicians. 95:1978-1988. 2020
Relationship of Body Mass Index With Outcomes After Transcatheter Aortic Valve Replacement: Results From the National Cardiovascular Data-STS/ACC TVT Registry. 95:57-68. 2020
UK Biobank Contributes to Aerobic and Muscle Fitness Research. 95:840-842. 2020
Association of Muscular Strength and Incidence of Type 2 Diabetes. 94:643-651. 2019
Atrial Fibrillation and Morbidity and Mortality in Stress-Induced Cardiomyopathy. 94:2146-2148. 2019
Atrial Fibrillation and Multimorbidity. 94:2381-2382. 2019
Cardiorespiratory Fitness and the Risk of Serious Ventricular Arrhythmias: A Prospective Cohort Study. 94:833-841. 2019
Cost-Sharing Deters Cardiac Rehabilitation Adherence. 94:2372-2374. 2019
Exercise Counteracts the Cardiotoxicity of Psychosocial Stress. 94:1852-1864. 2019
Exercise Versus Pharmacological Interventions for Reducing Visceral Adiposity and Improving Health Outcomes. 94:182-185. 2019
In reply-Atrial Fibrillation and Morbidity and Mortality in Stress-Induced Cardiomyopathy. 94:2148-2149. 2019
New Guidelines, Increasing Hypertension Numbers, Resistance and Resistance to Change?. 94:745-747. 2019
Physical Activity and Risk of Metabolic Phenotypes of Obesity: A Prospective Taiwanese Cohort Study in More Than 200,000 Adults. 94:2209-2219. 2019
Role of Muscular Strength on the Risk of Sudden Cardiac Death in Men. 94:2589-2591. 2019
Sea Change for Marine Omega-3s: Randomized Trials Show Fish Oil Reduces Cardiovascular Events. 94:2524-2533. 2019
Survival Benefit of Obese Patients With Pulmonary Embolism. 94:1960-1973. 2019
The Effects of Dietary Sugars on Cardiovascular Disease and Cardiovascular Disease-Related Mortality: Finding the Sweet Spot. 94:2375-2377. 2019
Cardiorespiratory Fitness and Health Outcomes: A Call to Standardize Fitness Categories. 93:333-336. 2018
Change in Submaximal Cardiorespiratory Fitness and All-Cause Mortality. 93:184-190. 2018
Health Literacy: An Important Clinical Tool in Heart Failure. 93:1-3. 2018
Long-term Changes in Depressive Symptoms and Estimated Cardiorespiratory Fitness and Risk of All-Cause Mortality: The Nord-Trondelag Health Study. 93:1054-1064. 2018
Nonexercise Estimated Cardiorespiratory Fitness and All-Cancer Mortality: the NHANES III Study. 93:848-856. 2018
Obesity, Central Adiposity, and Fitness: Understanding the Obesity Paradox in the Context of Other Cardiometabolic Parameters. 93:676-678. 2018
Racial Differences in the Association Between Nonexercise Estimated Cardiorespiratory Fitness and Incident Stroke. 93:884-894. 2018
Relationship Between Obesity and Survival in Patients Hospitalized for Hypertensive Emergency. 93:263-265. 2018
Seasonal and Geographic Patterns in Seeking Cardiovascular Health Information: An Analysis of the Online Search Trends. 93:1185-1190. 2018
Testosterone and Cardiovascular Health. 93:83-100. 2018
The Impact of Mediators of Health Literacy on Clinical Outcomes in Cardiovascular Diseases. 93:1700-1702. 2018
Various Leisure-Time Physical Activities Associated With Widely Divergent Life Expectancies: The Copenhagen City Heart Study. 93:1775-1785. 2018
Association of Resistance Exercise, Independent of and Combined With Aerobic Exercise, With the Incidence of Metabolic Syndrome. 92:1214-1222. 2017
Cardiorespiratory Fitness and All-Cause Mortality in Men With Emotional Distress. 92:918-924. 2017
Cardiorespiratory Fitness and Incidence of Major Adverse Cardiovascular Events in US Veterans: A Cohort Study. 92:39-48. 2017
In Reply II-Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids. 92:1007-1008. 2017
In Reply-Atrial Fibrillation: Interatrial Block May Be an Underdiagnosed and Easily Recognizable Risk Factor. 92:682-682. 2017
Obesity and Heart Failure: Focus on the Obesity Paradox. 92:266-279. 2017
Observations and Reflections on the Burden of Hospitalizations for Heart Failure. 92:175-178. 2017
Omega-3 Fatty Acid Therapy: The Tide Turns for a Fish Story. 92:1-3. 2017
Prediction of Cardiovascular Mortality by Estimated Cardiorespiratory Fitness Independent of Traditional Risk Factors: The HUNT Study. 92:218-227. 2017
Preventing Bad and Expensive Things From Happening by Taking the Healthy Living Polypill: Everyone Needs This Medicine. 92:483-487. 2017
Survival of the Fittestd-Promoting Fitness Throughout the Life Span. 92:1743-1745. 2017
Body Mass Index, the Most Widely Used But Also Widely Criticized Index: Would a Criterion Standard Measure of Total Body Fat Be a Better Predictor of Cardiovascular Disease Mortality?. 91:443-455. 2016
Cardiorespiratory Fitness and Risk of Sudden Cardiac Death in Men and Women in the United States: A Prospective Evaluation From the Aerobics Center Longitudinal Study. 91:849-857. 2016
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome: A Systematic Review of Randomized Controlled Trials. 91:1084-1093. 2016
Exercise Capacity and Atrial Fibrillation Risk in Veterans: A Cohort Study. 91:558-566. 2016
Running and Mortality: Is More Actually Worse?. 91:534-536. 2016
The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and Treatment. 91:1778-1810. 2016
A Discussion of the Refutation of Memory-Based Dietary Assessment Methods (M-BMs): The Rhetorical Defense of Pseudoscientific and Inadmissible Evidence. 90:1736-1739. 2015
Association of Cardiorespiratory Fitness With Coronary Heart Disease in Asymptomatic Men. 90:1372-1379. 2015
Associations Between Television Watching and Car Riding Behaviors and Development of Depressive Symptoms: A Prospective Study. 90:184-193. 2015
Effects of Running on Chronic Diseases and Cardiovascular and All-Cause Mortality. 90:1541-1552. 2015
Impact of Statins on Physical Activity and Fitness: Ally or Adversary?. 90:1314-1319. 2015
Influence of the Source of Social Support and Size of Social Network on All-Cause Mortality. 90:895-902. 2015
Prediction of All-Cause Mortality by the Left Atrial Volume Index in Patients With Normal Left Ventricular Filling Pressure and Preserved Ejection Fraction. 90:1499-1505. 2015
Secular Change in Cardiorespiratory Fitness and Body Composition of Women: The Aerobics Center Longitudinal Study. 90:43-52. 2015
The Healthy Lifestyle Team is Central to the Success of Accountable Care Organizations. 90:572-576. 2015
The Inadmissibility of What We Eat in America and NHANES Dietary Data in Nutrition and Obesity Research and the Scientific Formulation of National Dietary Guidelines. 90:911-926. 2015
Time to Focus on Preventing Coronary Artery Disease Through Exercise Training in Normoglycemic Individuals. 90:418-418. 2015
Alcohol and Cardiovascular Health: The Dose Makes the Poison . . . or the Remedy. 89:382-393. 2014
Association of Exercise Heart Rate Response and Incidence of Hypertension in Men. 89:1101-1107. 2014
Body Composition and Mortality in a Large Cohort With Preserved Ejection Fraction: Untangling the Obesity Paradox. 89:1072-1079. 2014
Exercising for Health and Longevity vs Peak Performance: Different Regimens for Different Goals. 89:1171-1175. 2014
Hospitalist Perspective on the Treatment of Skin and Soft Tissue Infections. 89:1436-1451. 2014
In reply-Is Coffee Harmful? If Looking for Longevity, Say Yes to the Coffee, No to the Sugar. 89:577-577. 2014
In reply-Resistance Training and Cancer Survival. 89:1465-1466. 2014
Moderate Cardiorespiratory Fitness Is Positively Associated With Resting Metabolic Rate in Young Adults. 89:763-771. 2014
Omega-3 and Prostate Cancer: Examining the Pertinent Evidence. 89:444-450. 2014
The Effect of Resistance Exercise on All-Cause Mortality in Cancer Survivors. 89:1108-1115. 2014
Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality. 88:1066-1074. 2013
Atrial Fibrillation in the 21st Century: A Current Understanding of Risk Factors and Primary Prevention Strategies. 88:394-409. 2013
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit. 88:431-437. 2013
Impact of Cardiorespiratory Fitness on the Obesity Paradox in Patients With Heart Failure. 88:251-258. 2013
In Reply-Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality. 88:1493-1494. 2013
In reply-Regarding L-Carnitine and Cardiovascular Disease. 88:900-901. 2013
L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis. 88:544-551. 2013
Maternal Inactivity: 45-Year Trends in Mothers' Use of Time. 88:1368-1377. 2013
Neutralizing the Adverse Prognosis of Coronary Artery Calcium. 88:806-812. 2013
Physical Activity Promotion in the Health Care System. 88:1446-1461. 2013
Promoting Health and Wellness in the Workplace: A Unique Opportunity to Establish Primary and Extended Secondary Cardiovascular Risk Reduction Programs. 88:605-617. 2013
Protective Role of Resting Heart Rate on All-Cause and Cardiovascular Disease Mortality. 88:1420-1426. 2013
Scientific Decision Making, Policy Decisions, and the Obesity Pandemic. 88:593-604. 2013
Validation of a Novel Protocol for Calculating Estimated Energy Requirements and Average Daily Physical Activity Ratio for the US Population: 2005-2006. 88:1398-1407. 2013
Can Vitamin D Deficiency Break Your Heart?. 87:412-413. 2012
Ideal Cardiovascular Health and Mortality: Aerobics Center Longitudinal Study. 87:944-952. 2012
Impaired Fasting Plasma Glucose and Stroke Risk reply. 87:209-210. 2012
Potential Adverse Cardiovascular Effects From Excessive Endurance Exercise. 87:587-595. 2012
Potential, but Unobserved, Adverse Cardiovascular Effects From Endurance Exercise Reply. 87:1133-1134. 2012
ST-Segment Elevation: Defined by the Company It Keeps. 87:610-613. 2012
The Obesity Paradox, Cardiorespiratory Fitness, and Coronary Heart Disease. 87:443-451. 2012
A Prospective Study of Fasting Plasma Glucose and Risk of Stroke in Asymptomatic Men. 86:1042-1049. 2011
Body Composition and Coronary Heart Disease Mortality-An Obesity or a Lean Paradox?. 86:857-864. 2011
Left Atrial Volume Index Predictive of Mortality Independent of Left Ventricular Geometry in a Large Clinical Cohort With Preserved Ejection Fraction. 86:730-737. 2011
Medication Errors in Patients With Severe Chronic Kidney Disease and Acute Coronary Syndrome: The Impact of Computer-Assisted Decision Support. 86:1161-1164. 2011
More on Body Fat Cutoff Points Reply. 86:584-585. 2011
Natriuretic Peptides as Markers of Cardiovascular Risk: The Story Continues. 86:1143-1145. 2011
Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus. 86:128-138. 2011
The Need for Randomized Trials to Prove the Safety and Efficacy of Parachutes, Bulletproof Vests, and Percutaneous Renal Intervention. 86:603-605. 2011
Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the "Obesity Paradox". 85:605-608. 2010
Maximal Exercise Electrocardiographic Responses and Coronary Heart Disease Mortality Among Men With Metabolic Syndrome. 85:239-246. 2010
Role of Oral Agents in Improving Cardiovascular Prognosis in Diabetes Mellitus Reply. 85:99-101. 2010
To B or Not to B: Is Non-High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B?. 85:446-450. 2010
Use of Body Fatness Cutoff Points reply. 85:1057-1058. 2010
Using Apolipoprotein B to Manage Dyslipidemia Reply. 85:771-772. 2010
Cardiopulmonary Stress Testing in Patients With Pulmonary Artery Hypertension. 84:939-939. 2009
Ergo-anthropometric Assessment Reply. 84:941-942. 2009
Exercise Training and Cardiac Rehabilitation in Primary and Secondary Prevention of Coronary Heart Disease. 84:373-383. 2009
Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach. 84:741-757. 2009
The Association Between Cardiorespiratory Fitness and Risk of All-Cause Mortality Among Women With Impaired Fasting Glucose or Undiagnosed Diabetes Mellitus. 84:780-786. 2009
Are all fish equally close to the heart? Reply. 83:724-725. 2008
Homocysteine: The Rubik's Cube of Cardiovascular Risk Factors. 83:1200-1202. 2008
Intensive lipid intervention in the post-ENHANCE era. 83:867-869. 2008
Is Carotid Intima-Media Thickness a Reliable Clinical Predictor? Reply. 83:1300-1301. 2008
Omega-3 fatty acids for cardioprotection. 83:324-332. 2008
Survival benefit with concomitant oral platelet therapy after coronary angiography and before ad hoc percutaneous coronary intervention. 83:978-979. 2008

International Standard Serial Number (ISSN)

0025-6196